Skip to main content
2025 CRT Conference Main banner
Back

Sreekanth Vemulapalli, MD

Associate Professor of Medicine
Duke University and Duke Clinical Research Institute
Durham, North Carolina, United States

Dr. Vemulapalli is an Associate Professor of Medicine / Cardiology and serves as the Medical Director of the Duke Echo Lab and Cardiac Diagnostic Unit as well as the leader of the Interventional Echocardiography group. He has significant experience with real world evidence generation, and research on medical devices in both structural heart disease and peripheral vascular disease. He currently serves as the PI of the STS / ACC Transcatheter Valve Therapies Registry analytic center at the DCRI as well as multiple NHLBI-funded clinical registries and trials. His current research interests include methods for linkages of claims and EHR data with clinical registries, and the application of machine learning techniques to cardiac imaging and clinical trials.

Disclosure(s): Abbott Vascular Devices: Consultant (Ongoing); Astra Zeneca: Consulting Fees (e.g., advisory boards) (Ongoing); Boehringer Ingelheim Pharmaceutical, Inc.: Consulting Fees (e.g., advisory boards) (Terminated, September 25, 2024); Cytokinetics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing)

Presentation(s):